Welcome message and department overview provided by Dr. Marc Lalande, professor and chair of Genetics and Genome Sciences and director, UConn Stem Cell Institute. Created in 1998, the Department of Genetics and Genome Sciences offers new and exciting opportunities for research and graduate education. The department is located in the Cell and Genome Sciences Building. All faculty members are actively contributing to research and education within the Schools of Medicine and Dental Medicine. The department is also the academic home of the Division of Medical Genetics. The division provides clinical and laboratory genetics services to the northern Connecticut region, and in some instances, throughout the state. Our faculty’s research interests include RNA processing, genetic control of cell growth and differentiation, skeletal development, signal transduction, as well as genetic and epigenetic mechanisms of gene regulation. In order to fulfill our departmental objectives, we will continue to increase external funding for our current research programs, enhance the national and international reputation of our faculty and their research, and continue the recruitment of outstanding faculty members with new and complementary areas of research expertise. Departmental faculties have played a key role in the formation of a University of Connecticut Institute for Stem Cell Research.
Stormy Chamberlain Named ASF SAC Chair
Stormy Chamberlain, world-renowned researcher of Angelman syndrome, has been named the new Scientific Advisory Committee (SAC) Chair for the Angelman Syndrome Foundation (read more).
Dr. Se-Jin Lee awarded NIH grant to study the regulation of tissue aging
Acclaimed UConn Health-JAX geneticist Dr. Se-Jin Lee and UConn Health-CCMC pediatric endocrinologist Dr. Emily Germain-Lee recently received a $1.9M grant from the National Institutes of Health for their project entitled: "TGF-beta family members and their binding proteins in aging skeletal muscle” (read more).
Stefan Pinter awarded R35 MIRA Grant from NIH
Dr. Pinter received a 5 year, $1.9M grant from the National Institute of Health for his project entitled: “Mechanisms of escaping X chromosome inactivation and translation to X-linked disease”.
This award uses X chromosome inactivation as a paradigm to learn how chromosome folding, non-coding RNAs, and chromatin modifiers enable some genes to remain active on the inactive X.